Announced
Synopsis
R-Biopharm, a provider of diagnostic technologies and products, agreed to acquire AusDiagnostics, a designer and manufacturer of diagnostic and testing equipments. Financial terms were not disclosed. “The existing and future molecular biology multiplex analysis platforms for syndrome testing from system supplier AusDiagnostics broadens our molecular biology expertise and perfectly complements our present clinical diagnostics portfolio. The acquisition strengthens our position as a reliable partner for system solutions and offers our customers additional options for diagnostics," Christian Dreher, R-Biopharm CEO.
Principals
Show Details & Financials
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.